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Surgery for Renovascular Disease: Long-Term Fol-
low-up of Patients Operated on during Fifteen Years
Johnny Steuer, Martin Björck, Christer Ljungman, Sandra
Jonasson, David Bergqvist. Institution of Surgical Sciences,
Department of Vascular Surgery, Uppsala University, Upp-
sala, Sweden
Objectives: To investigate the early and long-term
outcome after surgery for renovascular disease with empha-
sis on blood pressure control, renal function and survival.
Methods: During the 15-year period 1993-2007, a
total of 40 patients underwent open surgery for renovascu-
lar disease at our institution. The patients were followed for
up to five years with respect to postoperative morbidity,
including nephrectomy, dialysis dependency, vessel pa-
tency, blood pressure (BP) and renal function. Survival was
evaluated by cross-matching all patients with the popula-
tion-registry on Oct 1 2010.
Results: Of the 40 patients, 31 had renal artery steno-
sis, eight due to fibromuscular dysplasia (FMD), and 23
with predominantly atherosclerotic etiology (ARAS). Nine
were operated on for renal artery aneurysm (RAA). 16 of 23
patients with ARAS, 6/8 with FMD and 3/9 with RAA
were women.More than 2/3 of ARAS patients needed 3 or
more antihypertensive drugs, as did 2/3 of FMD patients
prior to surgery. The majority of FMD and RAA patients
had normal renal function, in 2/3 of ARAS patients it was
impaired. In FMD and RAA patients the disease involved
the right renal artery more often, whereas in ARAS patients
the disease was evenly distributed.
In ARAS and FMD patients, BP at 1 month and 1 year
had decreased post- compared to preoperatively, as had the
need for antihypertensive medication. No change in renal
function was observed. During follow-up, three patients
underwent PTRA for re-stenosis. Thirty-day mortality was
2.5%, caused by bowel ischemia in one ARAS patient.
Overall five-year survival was 87%. There was one late death
among FMD patients, 14 years after surgery. All RAA
patients were still alive. In ARAS patients five-year survival
was 78%. Median follow-up was 8.5 years.
Conclusions: Surgery for renovascular disease can be
performed with low morbidity and mortality, as well as a
very low need of re-interventions, and should still be con-
sidered as a therapeutic option in patients with complex
renovascular disease.
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Objectives: To examine our experience with open
surgical treatment of renal artery aneurysms(RAA).
Methods: All patients undergoing surgical repair of
RAAs between 1995 and 2010 were identified. Medical
records were retrospectively reviewed for comorbidities,
aneurysm characteristics, surgical approach and outcomes.
Results: Thirteen RAAs were identified in 12 patients.
One patient had 2 ipsilateral RAAs. Mean age was 49/
12 years and 11 were female. Two patients had concomi-
tant splenic artery aneurysms. Preoperatively, the mean
number of antiHTNmedications per patient was 1.4. Eight
patients presented with incidental RAAs and the rest had
flank pain. One patient presented with rupture and under-
went nephrectomy. All patients underwent preoperative
cross-sectional imaging, while 7 had angiography as well.
No patient had evidence of atheroemboli, renal infarcts,
renal artery dissection or renal artery stenosis by preopera-
tive imaging. Two patients had anatomically abnormal
contralateral kidneys(congenital absence and atrophy) but
no patients had abnormal renal function(mean Cr 0.8/
0.2 mg/dL). Comorbidities included HTN(7), fibromus-
cular dysplasia(1), and DM(1). The RAAs(mean diameter
2.9 / 1.4 cm; saccular5) were treated by either ex-
vivo reconstruction and autotransplantation(5), resection/
primary anastomosis(5), resection/saphenous vein inter-
position(1), resection/patch angioplasty (1), or
nephrectomy(1). Mean LOS was 6.4/ 1.4 days. Three
patients experienced 4 perioperative complications (ARF
2-both resolved, delirium1 and ureteral anastomotic
leak1). Thirty-day survival was 100%. Mean followup was
40months(7-140). All patients were alive at follow-up with
preserved renal function and no uncontrolled HTN.
Conclusions: Many RAA’s are not amenable to treat-
ment with endovascular techniques. Thus, open surgical
repair is still a mainstay of treatment and can be done with
minimal perioperative morbidity and mortality.
Author Disclosures: C. F. Barker: Nothing to disclose;
J. Carpenter: Nothing to disclose; R. M. Fairman: Noth-
ing to disclose; P. J. Foley: Nothing to disclose; B. M.
Jackson: Nothing to disclose;A. Naji: Nothing to disclose;
G. J. Wang: Nothing to disclose; E. Y. Woo: Nothing to
disclose.
PS72.
Blunt Abdominal Aortic Injury: Injury Patterns, Man-
agement, and Mortality
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